Bastar region will soon have its first super specialty hospital. Located in Jagdalpur, the facility opens in February. Hyderabad-based Continental Hospitals partners with the Chhattisgarh government. This 240-bedded hospital will offer advanced medical services.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4FoeWz6
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(40)
-
▼
January
(40)
- Sun Pharma gets DCGI nod to launch generic semaglu...
- Sun Pharma gets DCGI nod for Wegovy-like weight lo...
- New drugs could reach market sooner as govt halves...
- Bastar's first super-specialty hospital opens
- Budget 2026: Industry leaders seek funding framewo...
- Zydus launches biosimilar for treatment of multipl...
- Over 160 drug samples found sub-standard in December
- CDSCO finds over 160 drug samples as 'not of stand...
- Drug maker Lupin inks licensing pact with Galenicu...
- Delhi High Court denies interim protection to Alke...
- Novo Holdings buys 49% stake in Surya Hospitals
- Sun Pharma places non-binding offer for US-based O...
- Syngene expands research collaboration with Bristo...
- Sun Pharma clarifies $10 bn Organon acquisition re...
- Sun Pharma looks to rise in US with $10 billion Or...
- Brazil, Nigeria emerging as key export destination...
- PE backed ASG Eye hires Morgan Stanley and three o...
- IHCL to aquire 51% stake in Brij Hospitality
- Zydus Lifesciences gets USFDA nod for generic bloo...
- Delhi HC restores ban on 2 diabetes FDCs
- Dr Reddy's launches generic OTC ophthalmic solutio...
- Indian hospital chain Narayana Health eyes interna...
- Apollo Hospitals demerger is a biz call taken for ...
- Biocon arm gets USFDA nod for generic Everolimus t...
- Alembic Pharmaceuticals gets USFDA tentative nod f...
- Delhi HC clears Zydus to sell biosimilar of BMS ca...
- Budget 2026: Pharma, med-tech companies seek PLI e...
- Aurobindo Pharma’s Dyrupeg faces Health Canada com...
- Canadian pharmacy platform to offer India-sourced ...
- Cardiac drugs log highest sales in 2025 as NCD cas...
- Ayushman Bharat: UP cuts claim pendency sharply, s...
- Granules India gets USFDA tentative nod for generi...
- Future diabetes care seen leaning towards GLP-1 drugs
- Budget 2026: Volume to value - How India can get a...
- HC seeks Novo Nordisk's reply on Natco plea to rev...
- Biocon Biologics to introduce three new biosimilar...
- Max Healthcare partners with The Learning Lab for ...
- IIT Roorkee hosts 'AHEAD 2025' global health confe...
- Indian fertility experts advise caution on clinica...
- Budget for 'pharmacy of the world': What Sitharama...
-
▼
January
(40)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment